Oorsprong van het eerstegraads netwerk van Jonathan M. Hee
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA.
23
| Subsidiary | Pharmaceuticals: Major | 23 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jonathan M. Hee via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | President Chief Tech/Sci/R&D Officer | |
| ALLERGAN, INC. | Pharmaceuticals: Major | General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO General Counsel Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Sales & Marketing | |
| BIOGEN INC. | Pharmaceuticals: Major | Human Resources Officer | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| SENOMYX INC. | Food: Specialty/Candy | Chief Executive Officer Director/Board Member Human Resources Officer | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Sales & Marketing | |
| CUMBERLAND PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Operating Officer | |
VentiRx Pharmaceuticals, Inc.
 VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VentiRx Pharmaceuticals, Inc. develops and commercializes novel medicines for the treatment of cancer, respiratory, and inflammatory diseases. It focuses on the development of novel small molecule product candidates targeting toll-like receptor 8 for applications in oncology, allergy, autoimmune, and inflammatory diseases. The company was founded by Michael J. Kamdar and Robert Hershberg on June 12, 2006 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Rockhurst University | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Los Angeles | College/University | Doctorate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin | |
Smith College
 Smith College Other Consumer ServicesConsumer Services Smith College opened in 1875 with 14 students. Today, Smith is among the largest women’s colleges in Northampton, MA, with students from 48 states and 72 countries. The college remains strongly committed to the education of women at the undergraduate level, but Smith admits both men and women as graduate students. | College/University | Undergraduate Degree | |
| New York University | College/University | Doctorate Degree | |
| Purdue University | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Graduate Degree | |
| University of Dayton | College/University | Undergraduate Degree | |
| University of Kansas | College/University | Masters Business Admin Undergraduate Degree | |
| The University of Texas at Dallas | College/University | Doctorate Degree | |
| Wesleyan University | College/University | Undergraduate Degree | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| University of Lausanne | College/University | Doctorate Degree | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Profil Institute for Clinical Research, Inc.
 Profil Institute for Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Profil Institute for Clinical Research, Inc. operates as a full-service clinical research organization (CRO), that focuses on diabetes, obesity and NAFLD/NASH. It offers clinical development, regulatory affair, clinical research, scientific, data management and statistical, monitoring, quality and compliance, and recruitment services. The company was founded in 2004 and is headquartered in Chula Vista, CA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Parke-Davis Pharmaceutical Research, Inc. | Corporate Officer/Principal | ||
| BIOATLA, INC. | Biotechnology | Director/Board Member Human Resources Officer | |
| G.D. Searle LLC | Corporate Officer/Principal | ||
Sova Pharmaceuticals, Inc.
 Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Founder | |
| IMAGO BIOSCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| University of California Irvine School of Medicine | College/University | Masters Business Admin | |
| INMUNE BIO, INC. | Biotechnology | Director/Board Member | |
CoImmune, Inc.
 CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Founder | |
| Baracchini Consulting LLC | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Canada | 3 |
| Frankrijk | 2 |
| Zwitserland | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 15 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
| Miscellaneous | 2 |
Operationeel
| Corporate Officer/Principal | 59 |
| Director/Board Member | 35 |
| Undergraduate Degree | 21 |
| Independent Dir/Board Member | 14 |
| Chief Tech/Sci/R&D Officer | 13 |
Sterkste connecties
| Insiders | |
|---|---|
| Edgardo Baracchini | 13 |
| Michael J. Kamdar | 13 |
| Stephen Worland | 12 |
| Mark Brian Anderson | 11 |
| James R. Thomas | 10 |
| Martin Mattingly | 10 |
| Neil James Clendeninn | 9 |
| Karen Potts | 9 |
| Siegfried Reich | 8 |
| Donald D. Tartre | 8 |
| Colin E. Rowlings | 7 |
| John W. Poyhonen | 7 |
| Leo Pavliv | 7 |
| Sharon Real | 7 |
| Kent Snyder | 7 |
- Beurs
- Insiders
- Jonathan M. Hee
- Bedrijfsconnecties